NASDAQ · Financial Statements
Albireo Pharma, Inc. (ALBO) Financial Statements
$44.15
NASDAQ: ALBO
Market Cap $915.89M
Overview Financials Dividend Albireo Pharma, Inc. most recently reported annual revenue of $41.0M, net profit of $-151.0M, revenue has compounded at 30.1% a year over the last five years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2017 2018 2019 2020 2021 Revenue $0 $13.0M $10.0M $8.0M $41.0M Operating Profit $-25.0M $-38.0M $-61.0M $-96.0M $-123.0M Net Profit $-24.0M $-46.0M $-72.0M $-119.0M $-151.0M EPS $-3.12 $-3.94 $-5.77 $-7.45 $-7.87 Op Margin -2457700.0% -297.4% -634.2% -1158.8% -304.3%
Balance Sheet (USD)
Metric 2017 2018 2019 2020 2021 Total Assets $73.0M $185.0M $165.0M $286.0M $302.0M Total Liabilities $8.0M $63.0M $72.0M $104.0M $126.0M Cash $53.0M $164.0M $132.0M $251.0M $248.0M Borrowings $0 $0 $0 $10.0M $10.0M
Cash Flow (USD)
Metric 2017 2018 2019 2020 2021 Operating Cash Flow $-28.0M $-27.0M $-53.0M $-101.0M $-108.0M Investing Cash Flow $4.0M $0 $-1.0M $0 $102.0M Financing Cash Flow $46.0M $139.0M $24.0M $220.0M $3.0M Net Cash Flow $23.0M $111.0M $-32.0M $119.0M $-3.0M Free Cash Flow $-28.0M $-27.0M $-53.0M $-101.0M $-108.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.02 EV / EBITDA -34.19 FCF Yield -11.79% Quick Ratio 5.93 Interest Coverage -8.86 Return 1Y — Return 3Y — Return 5Y —
Screens featuring this stock